Trophinin-associated protein expression is an independent prognostic biomarker in lung adenocarcinoma
- PMID: 31285897
- PMCID: PMC6588746
- DOI: 10.21037/jtd.2019.04.86
Trophinin-associated protein expression is an independent prognostic biomarker in lung adenocarcinoma
Abstract
Background: Lung cancer is the leading cause of cancer-related deaths worldwide, with lung adenocarcinoma (LAC) representing the most common subtype. Trophinin-associated protein (TROAP) is a cytoplasmic protein first identified to mediate the process of embryo transplantation, which has been recently found to be involved in microtubule regulation. However, limited information about the role of TROAP in LAC is available.
Methods: We evaluated the relationship of TROAP expression in LAC tissues with clinical pathologic parameters and the survival time in LAC patients based on a statistical analysis of The Cancer Genome Atlas (TCGA) lung cancer data (N=528). Differences in survival between high and low expression groups (median expression cutoff) from the Cox univariate/multivariate regression analysis were then compared.
Results: According to the Chi-square tests, we found high TROAP expression correlated with younger age (≤60) (P=0.047), male sex (P<0.005), an earlier T-stage (P=0.011), N-stage (P=0.017), M-stage (P=0.022), TNM (P=0.007), and a longer smoking history (>30 pack-year) (P<0.001). A Kaplan-Meier analysis demonstrated that high TROAP expression may correspond with poor overall survival of LAC patients in T3 stage (P=0.0013), N0 stage (P=0.014), and M0 stage (P=0.0023). Multivariate analysis confirmed that TROAP expression was related to overall survival in LAC patients independently [hazard ratio (HR): 1.784, 95% confidence interval (CI): 1.072-2.968, P=0.026].
Conclusions: Our results suggested that TROAP is an independent prognostic biomarker of poor survival in LAC.
Keywords: The Cancer Genome Atlas (TCGA); Trophinin-associated protein (TROAP); biomarker; lung adenocarcinoma (LAC).
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers.Front Oncol. 2022 Nov 7;12:971618. doi: 10.3389/fonc.2022.971618. eCollection 2022. Front Oncol. 2022. PMID: 36419876 Free PMC article.
-
High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.Dig Dis Sci. 2019 Jan;64(1):137-143. doi: 10.1007/s10620-018-5315-x. Epub 2018 Oct 4. Dig Dis Sci. 2019. PMID: 30284652
-
The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma.J Cancer. 2019 Jan 29;10(4):957-967. doi: 10.7150/jca.26666. eCollection 2019. J Cancer. 2019. PMID: 30854102 Free PMC article.
-
Trophinin-associated protein expression correlates with shorter survival of patients with glioma: a study based on multiple data fusion analysis.Mol Biol Rep. 2022 Aug;49(8):7899-7909. doi: 10.1007/s11033-022-07622-8. Epub 2022 Jun 16. Mol Biol Rep. 2022. PMID: 35708862
-
High trophinin-associated protein expression predicts good survival in acute myeloid leukemia with normal cytogenetics.Cancer Biomark. 2023;36(3):221-230. doi: 10.3233/CBM-210042. Cancer Biomark. 2023. PMID: 36938721
Cited by
-
Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma.MedComm (2020). 2023 Sep 18;4(5):e369. doi: 10.1002/mco2.369. eCollection 2023 Oct. MedComm (2020). 2023. PMID: 37731946 Free PMC article.
-
METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway.Med Oncol. 2023 Aug 22;40(9):274. doi: 10.1007/s12032-023-02143-1. Med Oncol. 2023. PMID: 37608033
-
Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma.Saudi J Biol Sci. 2023 Apr;30(4):103596. doi: 10.1016/j.sjbs.2023.103596. Epub 2023 Feb 11. Saudi J Biol Sci. 2023. PMID: 36879671 Free PMC article.
-
Tastin promotes non-small-cell lung cancer progression through the ErbB4, PI3K/AKT, and ERK1/2 pathways.Exp Biol Med (Maywood). 2023 Mar;248(6):519-531. doi: 10.1177/15353702221147566. Epub 2023 Jan 23. Exp Biol Med (Maywood). 2023. PMID: 36691332 Free PMC article.
-
Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers.Front Oncol. 2022 Nov 7;12:971618. doi: 10.3389/fonc.2022.971618. eCollection 2022. Front Oncol. 2022. PMID: 36419876 Free PMC article.
References
LinkOut - more resources
Full Text Sources